7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $476M | $78M | 84.2% | 14.0% | $160M | — | $124M |
| 2024 | $401M | -$283M | 84.4% | 14.2% | $124M | — | $192M |
| 2023 | $325M | -$81M | 83.6% | 10.2% | $97M | — | $190M |
| 2022 | $271M | $121M | 81.3% | 0.4% | $14M | — | $88M |
| 2021 | $246M | $71M | 82.7% | 5.6% | $31M | — | $146M |
| 2020 | $195M | $6M | 80.6% | 4.7% | $60M | — | — |
| 2019 | $172M | -$2M | 79.2% | -0.9% | $10M | — | — |
How the market has priced CLBT against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Cellebrite Di Ltd.'s revenue has grown 19.5% per year, and net income grown 68.4% per year. These are computed facts, not advice.
As of FY2025, Cellebrite Di Ltd. reported — of total debt against $124M of cash.
In FY2025, gross margin was 84.2%, operating margin 14.0%, and net margin 16.5%.
As of Jun '26, Cellebrite Di Ltd. traded at a price-to-earnings ratio of about 40.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.